Authors: Morecki, S Yacovlev, E Gelfand, Y Uzi, I Slavin, S

Citation: S. Morecki et al., Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma, J IMMUNOTH, 24(2), 2001, pp. 114-121

Authors: Slavin, S Ackerstein, A Morecki, S Gelfand, Y Cividalli, G

Citation: S. Slavin et al., Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes, BONE MAR TR, 28(8), 2001, pp. 795-798

Authors: Morecki, S Gelfand, Y Nagler, A Or, R Naparstek, E Varadi, G Engelhard, D Akerstein, A Slavin, S

Citation: S. Morecki et al., Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen, BONE MAR TR, 28(3), 2001, pp. 243-249

Authors: Morecki, S Slavin, S

Citation: S. Morecki et S. Slavin, Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease, J HEMATH ST, 9(3), 2000, pp. 355-366

Authors: Morecki, S Yacovlev, E Gelfand, Y Trembovler, V Shohami, E Slavin, S

Citation: S. Morecki et al., Induction of antitumor immunity by indomethacin, CANCER IMMU, 48(11), 2000, pp. 613-620

Authors: Slavin, S Morecki, S Naparstek, E Nagler, A Varadi, G Ben-Yosef, R Or, R

Citation: S. Slavin et al., Adoptive allogeneic cell-mediated immunotherapy and nonmyeloablative stem-cell transplantation, BAS CLIN ON, 22, 2000, pp. 255-266